Malysheva Kh V, Spasyuk I M, Pavlenko O K, Stoika R S, Gorchynskyi O G
Ukr Biochem J. 2016 Nov-Dec;88(6):87-97. doi: 10.15407/ubj88.06.087.
Correction of inherited skeletal abnormalities, traumas affecting wide bone areas and non-healing fractures require efficient bone formation and regeneration. Bone morphogenetic proteins (BMPs) are signaling molecules that play a crucial role in bone and cartilage formation and regeneration. Osteoinductive properties of existing hydroxyapatite-based osteoplastic materials are frequently insufficient for efficient bone regeneration, thus raising a requirement for novel matrices involving BMPs for highly efficient local induction of bone formation at the area of the bone defect. The aim of this study was conducting in vitro optimization of osteoinductive properties of recombinant BMPs preparations to be used in bone regenerative practice. Recombinant BMPs were produced in human embryonic kidney 293 cells upon their transfection or co-transfection with plasmids expressing BMP2 and BMP7 at different ratios. A quality of BMP preps was validated based on their ability to induce in vitro osteoblast differentiation of C2C12 cells. Alkaline phosphatase that is widely used as a marker of osteoblast differentiation was measured spectrophotometrically. We found that the most effective inducer of osteoblast differentiation was recombinant BMP preparation produced upon cotransfection of 85% of BMP2 and 15% of BMP7 plasmids, that is most likely due to generation of conditions most favorable for formation of BMP2/7 heterodimers. Frozen BMP2/7 preparations stored for 3 h in experimental setup and for several weeks in routine work do not lose their osteoinductive properties compared with freshly prepared BMP2/7 preparations and can be successfully used for generation of highly efficient bone regenerative matrices.
矫正遗传性骨骼异常、影响大面积骨骼的创伤以及不愈合骨折需要有效的骨形成和再生。骨形态发生蛋白(BMPs)是在骨和软骨形成及再生中起关键作用的信号分子。现有的基于羟基磷灰石的骨塑性材料的骨诱导特性常常不足以实现有效的骨再生,因此需要新型基质,其中包含BMPs,以在骨缺损区域高效地局部诱导骨形成。本研究的目的是对用于骨再生实践的重组BMP制剂的骨诱导特性进行体外优化。重组BMPs是在人胚胎肾293细胞转染或共转染不同比例表达BMP2和BMP7的质粒后产生的。基于其诱导C2C12细胞体外成骨细胞分化的能力来验证BMP制剂的质量。使用分光光度法测量广泛用作成骨细胞分化标志物的碱性磷酸酶。我们发现,成骨细胞分化的最有效诱导剂是在共转染85%的BMP2和15%的BMP7质粒后产生的重组BMP制剂,这很可能是由于产生了最有利于形成BMP2/7异二聚体的条件。与新鲜制备的BMP2/7制剂相比,在实验装置中储存3小时以及在常规工作中储存数周的冷冻BMP2/7制剂不会丧失其骨诱导特性,并且可以成功用于生成高效的骨再生基质。